TY - JOUR
T1 - An ingestible, battery-free, tissue-adhering robotic interface for non-invasive and chronic electrostimulation of the gut
AU - Nan, Kewang
AU - Wong, Kiwan
AU - Li, Dengfeng
AU - Ying, Binbin
AU - McRae, James C.
AU - Feig, Vivian R.
AU - Wang, Shubing
AU - Du, Ningjie
AU - Liang, Yuelong
AU - Mao, Qijiang
AU - Zhou, Enjie
AU - Chen, Yonglin
AU - Sang, Lei
AU - Yao, Kuanming
AU - Zhou, Jingkun
AU - Li, Jian
AU - Jenkins, Joshua
AU - Ishida, Keiko
AU - Kuosmanen, Johannes
AU - Mohammed Madani, Wiam Abdalla
AU - Hayward, Alison
AU - Ramadi, Khalil B.
AU - Yu, Xinge
AU - Traverso, Giovanni
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/12
Y1 - 2024/12
N2 - Ingestible electronics have the capacity to transform our ability to effectively diagnose and potentially treat a broad set of conditions. Current applications could be significantly enhanced by addressing poor electrode-tissue contact, lack of navigation, short dwell time, and limited battery life. Here we report the development of an ingestible, battery-free, and tissue-adhering robotic interface (IngRI) for non-invasive and chronic electrostimulation of the gut, which addresses challenges associated with contact, navigation, retention, and powering (C-N-R-P) faced by existing ingestibles. We show that near-field inductive coupling operating near 13.56 MHz was sufficient to power and modulate the IngRI to deliver therapeutically relevant electrostimulation, which can be further enhanced by a bio-inspired, hydrogel-enabled adhesive interface. In swine models, we demonstrated the electrical interaction of IngRI with the gastric mucosa by recording conductive signaling from the subcutaneous space. We further observed changes in plasma ghrelin levels, the “hunger hormone,” while IngRI was activated in vivo, demonstrating its clinical potential in regulating appetite and treating other endocrine conditions. The results of this study suggest that concepts inspired by soft and wireless skin-interfacing electronic devices can be applied to ingestible electronics with potential clinical applications for evaluating and treating gastrointestinal conditions.
AB - Ingestible electronics have the capacity to transform our ability to effectively diagnose and potentially treat a broad set of conditions. Current applications could be significantly enhanced by addressing poor electrode-tissue contact, lack of navigation, short dwell time, and limited battery life. Here we report the development of an ingestible, battery-free, and tissue-adhering robotic interface (IngRI) for non-invasive and chronic electrostimulation of the gut, which addresses challenges associated with contact, navigation, retention, and powering (C-N-R-P) faced by existing ingestibles. We show that near-field inductive coupling operating near 13.56 MHz was sufficient to power and modulate the IngRI to deliver therapeutically relevant electrostimulation, which can be further enhanced by a bio-inspired, hydrogel-enabled adhesive interface. In swine models, we demonstrated the electrical interaction of IngRI with the gastric mucosa by recording conductive signaling from the subcutaneous space. We further observed changes in plasma ghrelin levels, the “hunger hormone,” while IngRI was activated in vivo, demonstrating its clinical potential in regulating appetite and treating other endocrine conditions. The results of this study suggest that concepts inspired by soft and wireless skin-interfacing electronic devices can be applied to ingestible electronics with potential clinical applications for evaluating and treating gastrointestinal conditions.
UR - http://www.scopus.com/inward/record.url?scp=85200919307&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85200919307&partnerID=8YFLogxK
U2 - 10.1038/s41467-024-51102-5
DO - 10.1038/s41467-024-51102-5
M3 - Article
C2 - 39117667
AN - SCOPUS:85200919307
SN - 2041-1723
VL - 15
JO - Nature communications
JF - Nature communications
IS - 1
M1 - 6749
ER -